NCT06496997View on ClinicalTrials.gov

A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Acute Respiratory Distress Syndrome
Interventions
DRUG

Methylprednisolone

Methylprednisolone at a dose of 1 mg/kg/day (an average dose of 70 mg/day based on 70 kg body weight)

DRUG

Dexamethasone

Dexamethasone at an equivalent dose of 13 mg/day

DRUG

Hydrocortisone

Hydrocortisone at an equivalent dose of 350 mg/day

Trial Locations (1)

Unknown

RECRUITING

Fayoum University, Al Fayyum

All Listed Sponsors
lead

Fayoum University

OTHER